
Biological augmentation is the addition of archaea or bacterial cultures required to speed up the rate of degradation of a contaminant.
Âé¶¹Ô´´ Analysis and Insights: Global Biological Augmentation Services Âé¶¹Ô´´
The global Biological Augmentation Services market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Biological Augmentation Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Biological Augmentation Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Biological Augmentation Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Biological Augmentation Services include Black Lagoon, SOLitude Lake Management, Estate Management Services, LakePro, OMEX, RF WasteWater, SUEZ, Aquatic Biologists and Parklink, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Biological Augmentation Services market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Biological Augmentation Services, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Biological Augmentation Services, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biological Augmentation Services revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Biological Augmentation Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Biological Augmentation Services revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Black Lagoon, SOLitude Lake Management, Estate Management Services, LakePro, OMEX, RF WasteWater, SUEZ, Aquatic Biologists and Parklink, etc.
By Company
Black Lagoon
SOLitude Lake Management
Estate Management Services
LakePro
OMEX
RF WasteWater
SUEZ
Aquatic Biologists
Parklink
WET USA
Barber's Chemicals
Madep
Amanzi Matters
Cholamandalam MS Risk Services
Cellozyme
Skyhawk Global
Hagan Engineering
Kurita Water Industries
MER Chemical Laboratory and Services
Lake Management
Acti-Zyme
Aquatic Plus Pond Management
Oxybeesolutions
Segment by Type
Archaea
Bacterial
Segment by Application
Industrial
Agricultural
Municipal
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Biological Augmentation Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biological Augmentation Services companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biological Augmentation Services revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Biological Augmentation Services Âé¶¹Ô´´ Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Archaea
1.2.3 Bacterial
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Biological Augmentation Services Âé¶¹Ô´´ Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Industrial
1.3.3 Agricultural
1.3.4 Municipal
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biological Augmentation Services Âé¶¹Ô´´ Perspective (2018-2029)
2.2 Global Biological Augmentation Services Growth Trends by Region
2.2.1 Biological Augmentation Services Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biological Augmentation Services Historic Âé¶¹Ô´´ Size by Region (2018-2023)
2.2.3 Biological Augmentation Services Forecasted Âé¶¹Ô´´ Size by Region (2024-2029)
2.3 Biological Augmentation Services Âé¶¹Ô´´ Dynamics
2.3.1 Biological Augmentation Services Industry Trends
2.3.2 Biological Augmentation Services Âé¶¹Ô´´ Drivers
2.3.3 Biological Augmentation Services Âé¶¹Ô´´ Challenges
2.3.4 Biological Augmentation Services Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Biological Augmentation Services by Players
3.1.1 Global Biological Augmentation Services Revenue by Players (2018-2023)
3.1.2 Global Biological Augmentation Services Revenue Âé¶¹Ô´´ Share by Players (2018-2023)
3.2 Global Biological Augmentation Services Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biological Augmentation Services, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Biological Augmentation Services Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Biological Augmentation Services Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biological Augmentation Services Revenue in 2022
3.5 Global Key Players of Biological Augmentation Services Head office and Area Served
3.6 Global Key Players of Biological Augmentation Services, Product and Application
3.7 Global Key Players of Biological Augmentation Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biological Augmentation Services Breakdown Data by Type
4.1 Global Biological Augmentation Services Historic Âé¶¹Ô´´ Size by Type (2018-2023)
4.2 Global Biological Augmentation Services Forecasted Âé¶¹Ô´´ Size by Type (2024-2029)
5 Biological Augmentation Services Breakdown Data by Application
5.1 Global Biological Augmentation Services Historic Âé¶¹Ô´´ Size by Application (2018-2023)
5.2 Global Biological Augmentation Services Forecasted Âé¶¹Ô´´ Size by Application (2024-2029)
6 North America
6.1 North America Biological Augmentation Services Âé¶¹Ô´´ Size (2018-2029)
6.2 North America Biological Augmentation Services Âé¶¹Ô´´ Size by Type
6.2.1 North America Biological Augmentation Services Âé¶¹Ô´´ Size by Type (2018-2023)
6.2.2 North America Biological Augmentation Services Âé¶¹Ô´´ Size by Type (2024-2029)
6.2.3 North America Biological Augmentation Services Âé¶¹Ô´´ Share by Type (2018-2029)
6.3 North America Biological Augmentation Services Âé¶¹Ô´´ Size by Application
6.3.1 North America Biological Augmentation Services Âé¶¹Ô´´ Size by Application (2018-2023)
6.3.2 North America Biological Augmentation Services Âé¶¹Ô´´ Size by Application (2024-2029)
6.3.3 North America Biological Augmentation Services Âé¶¹Ô´´ Share by Application (2018-2029)
6.4 North America Biological Augmentation Services Âé¶¹Ô´´ Size by Country
6.4.1 North America Biological Augmentation Services Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Biological Augmentation Services Âé¶¹Ô´´ Size by Country (2018-2023)
6.4.3 North America Biological Augmentation Services Âé¶¹Ô´´ Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Biological Augmentation Services Âé¶¹Ô´´ Size (2018-2029)
7.2 Europe Biological Augmentation Services Âé¶¹Ô´´ Size by Type
7.2.1 Europe Biological Augmentation Services Âé¶¹Ô´´ Size by Type (2018-2023)
7.2.2 Europe Biological Augmentation Services Âé¶¹Ô´´ Size by Type (2024-2029)
7.2.3 Europe Biological Augmentation Services Âé¶¹Ô´´ Share by Type (2018-2029)
7.3 Europe Biological Augmentation Services Âé¶¹Ô´´ Size by Application
7.3.1 Europe Biological Augmentation Services Âé¶¹Ô´´ Size by Application (2018-2023)
7.3.2 Europe Biological Augmentation Services Âé¶¹Ô´´ Size by Application (2024-2029)
7.3.3 Europe Biological Augmentation Services Âé¶¹Ô´´ Share by Application (2018-2029)
7.4 Europe Biological Augmentation Services Âé¶¹Ô´´ Size by Country
7.4.1 Europe Biological Augmentation Services Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Biological Augmentation Services Âé¶¹Ô´´ Size by Country (2018-2023)
7.4.3 Europe Biological Augmentation Services Âé¶¹Ô´´ Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Biological Augmentation Services Âé¶¹Ô´´ Size (2018-2029)
8.2 China Biological Augmentation Services Âé¶¹Ô´´ Size by Type
8.2.1 China Biological Augmentation Services Âé¶¹Ô´´ Size by Type (2018-2023)
8.2.2 China Biological Augmentation Services Âé¶¹Ô´´ Size by Type (2024-2029)
8.2.3 China Biological Augmentation Services Âé¶¹Ô´´ Share by Type (2018-2029)
8.3 China Biological Augmentation Services Âé¶¹Ô´´ Size by Application
8.3.1 China Biological Augmentation Services Âé¶¹Ô´´ Size by Application (2018-2023)
8.3.2 China Biological Augmentation Services Âé¶¹Ô´´ Size by Application (2024-2029)
8.3.3 China Biological Augmentation Services Âé¶¹Ô´´ Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Biological Augmentation Services Âé¶¹Ô´´ Size (2018-2029)
9.2 Asia Biological Augmentation Services Âé¶¹Ô´´ Size by Type
9.2.1 Asia Biological Augmentation Services Âé¶¹Ô´´ Size by Type (2018-2023)
9.2.2 Asia Biological Augmentation Services Âé¶¹Ô´´ Size by Type (2024-2029)
9.2.3 Asia Biological Augmentation Services Âé¶¹Ô´´ Share by Type (2018-2029)
9.3 Asia Biological Augmentation Services Âé¶¹Ô´´ Size by Application
9.3.1 Asia Biological Augmentation Services Âé¶¹Ô´´ Size by Application (2018-2023)
9.3.2 Asia Biological Augmentation Services Âé¶¹Ô´´ Size by Application (2024-2029)
9.3.3 Asia Biological Augmentation Services Âé¶¹Ô´´ Share by Application (2018-2029)
9.4 Asia Biological Augmentation Services Âé¶¹Ô´´ Size by Region
9.4.1 Asia Biological Augmentation Services Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Biological Augmentation Services Âé¶¹Ô´´ Size by Region (2018-2023)
9.4.3 Asia Biological Augmentation Services Âé¶¹Ô´´ Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Biological Augmentation Services Âé¶¹Ô´´ Size (2018-2029)
10.2 Middle East, Africa, and Latin America Biological Augmentation Services Âé¶¹Ô´´ Size by Type
10.2.1 Middle East, Africa, and Latin America Biological Augmentation Services Âé¶¹Ô´´ Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Biological Augmentation Services Âé¶¹Ô´´ Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Biological Augmentation Services Âé¶¹Ô´´ Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Biological Augmentation Services Âé¶¹Ô´´ Size by Application
10.3.1 Middle East, Africa, and Latin America Biological Augmentation Services Âé¶¹Ô´´ Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Biological Augmentation Services Âé¶¹Ô´´ Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Biological Augmentation Services Âé¶¹Ô´´ Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Biological Augmentation Services Âé¶¹Ô´´ Size by Country
10.4.1 Middle East, Africa, and Latin America Biological Augmentation Services Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Biological Augmentation Services Âé¶¹Ô´´ Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Biological Augmentation Services Âé¶¹Ô´´ Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Black Lagoon
11.1.1 Black Lagoon Company Details
11.1.2 Black Lagoon Business Overview
11.1.3 Black Lagoon Biological Augmentation Services Introduction
11.1.4 Black Lagoon Revenue in Biological Augmentation Services Business (2018-2023)
11.1.5 Black Lagoon Recent Developments
11.2 SOLitude Lake Management
11.2.1 SOLitude Lake Management Company Details
11.2.2 SOLitude Lake Management Business Overview
11.2.3 SOLitude Lake Management Biological Augmentation Services Introduction
11.2.4 SOLitude Lake Management Revenue in Biological Augmentation Services Business (2018-2023)
11.2.5 SOLitude Lake Management Recent Developments
11.3 Estate Management Services
11.3.1 Estate Management Services Company Details
11.3.2 Estate Management Services Business Overview
11.3.3 Estate Management Services Biological Augmentation Services Introduction
11.3.4 Estate Management Services Revenue in Biological Augmentation Services Business (2018-2023)
11.3.5 Estate Management Services Recent Developments
11.4 LakePro
11.4.1 LakePro Company Details
11.4.2 LakePro Business Overview
11.4.3 LakePro Biological Augmentation Services Introduction
11.4.4 LakePro Revenue in Biological Augmentation Services Business (2018-2023)
11.4.5 LakePro Recent Developments
11.5 OMEX
11.5.1 OMEX Company Details
11.5.2 OMEX Business Overview
11.5.3 OMEX Biological Augmentation Services Introduction
11.5.4 OMEX Revenue in Biological Augmentation Services Business (2018-2023)
11.5.5 OMEX Recent Developments
11.6 RF WasteWater
11.6.1 RF WasteWater Company Details
11.6.2 RF WasteWater Business Overview
11.6.3 RF WasteWater Biological Augmentation Services Introduction
11.6.4 RF WasteWater Revenue in Biological Augmentation Services Business (2018-2023)
11.6.5 RF WasteWater Recent Developments
11.7 SUEZ
11.7.1 SUEZ Company Details
11.7.2 SUEZ Business Overview
11.7.3 SUEZ Biological Augmentation Services Introduction
11.7.4 SUEZ Revenue in Biological Augmentation Services Business (2018-2023)
11.7.5 SUEZ Recent Developments
11.8 Aquatic Biologists
11.8.1 Aquatic Biologists Company Details
11.8.2 Aquatic Biologists Business Overview
11.8.3 Aquatic Biologists Biological Augmentation Services Introduction
11.8.4 Aquatic Biologists Revenue in Biological Augmentation Services Business (2018-2023)
11.8.5 Aquatic Biologists Recent Developments
11.9 Parklink
11.9.1 Parklink Company Details
11.9.2 Parklink Business Overview
11.9.3 Parklink Biological Augmentation Services Introduction
11.9.4 Parklink Revenue in Biological Augmentation Services Business (2018-2023)
11.9.5 Parklink Recent Developments
11.10 WET USA
11.10.1 WET USA Company Details
11.10.2 WET USA Business Overview
11.10.3 WET USA Biological Augmentation Services Introduction
11.10.4 WET USA Revenue in Biological Augmentation Services Business (2018-2023)
11.10.5 WET USA Recent Developments
11.11 Barber's Chemicals
11.11.1 Barber's Chemicals Company Details
11.11.2 Barber's Chemicals Business Overview
11.11.3 Barber's Chemicals Biological Augmentation Services Introduction
11.11.4 Barber's Chemicals Revenue in Biological Augmentation Services Business (2018-2023)
11.11.5 Barber's Chemicals Recent Developments
11.12 Madep
11.12.1 Madep Company Details
11.12.2 Madep Business Overview
11.12.3 Madep Biological Augmentation Services Introduction
11.12.4 Madep Revenue in Biological Augmentation Services Business (2018-2023)
11.12.5 Madep Recent Developments
11.13 Amanzi Matters
11.13.1 Amanzi Matters Company Details
11.13.2 Amanzi Matters Business Overview
11.13.3 Amanzi Matters Biological Augmentation Services Introduction
11.13.4 Amanzi Matters Revenue in Biological Augmentation Services Business (2018-2023)
11.13.5 Amanzi Matters Recent Developments
11.14 Cholamandalam MS Risk Services
11.14.1 Cholamandalam MS Risk Services Company Details
11.14.2 Cholamandalam MS Risk Services Business Overview
11.14.3 Cholamandalam MS Risk Services Biological Augmentation Services Introduction
11.14.4 Cholamandalam MS Risk Services Revenue in Biological Augmentation Services Business (2018-2023)
11.14.5 Cholamandalam MS Risk Services Recent Developments
11.15 Cellozyme
11.15.1 Cellozyme Company Details
11.15.2 Cellozyme Business Overview
11.15.3 Cellozyme Biological Augmentation Services Introduction
11.15.4 Cellozyme Revenue in Biological Augmentation Services Business (2018-2023)
11.15.5 Cellozyme Recent Developments
11.16 Skyhawk Global
11.16.1 Skyhawk Global Company Details
11.16.2 Skyhawk Global Business Overview
11.16.3 Skyhawk Global Biological Augmentation Services Introduction
11.16.4 Skyhawk Global Revenue in Biological Augmentation Services Business (2018-2023)
11.16.5 Skyhawk Global Recent Developments
11.17 Hagan Engineering
11.17.1 Hagan Engineering Company Details
11.17.2 Hagan Engineering Business Overview
11.17.3 Hagan Engineering Biological Augmentation Services Introduction
11.17.4 Hagan Engineering Revenue in Biological Augmentation Services Business (2018-2023)
11.17.5 Hagan Engineering Recent Developments
11.18 Kurita Water Industries
11.18.1 Kurita Water Industries Company Details
11.18.2 Kurita Water Industries Business Overview
11.18.3 Kurita Water Industries Biological Augmentation Services Introduction
11.18.4 Kurita Water Industries Revenue in Biological Augmentation Services Business (2018-2023)
11.18.5 Kurita Water Industries Recent Developments
11.19 MER Chemical Laboratory and Services
11.19.1 MER Chemical Laboratory and Services Company Details
11.19.2 MER Chemical Laboratory and Services Business Overview
11.19.3 MER Chemical Laboratory and Services Biological Augmentation Services Introduction
11.19.4 MER Chemical Laboratory and Services Revenue in Biological Augmentation Services Business (2018-2023)
11.19.5 MER Chemical Laboratory and Services Recent Developments
11.20 Lake Management
11.20.1 Lake Management Company Details
11.20.2 Lake Management Business Overview
11.20.3 Lake Management Biological Augmentation Services Introduction
11.20.4 Lake Management Revenue in Biological Augmentation Services Business (2018-2023)
11.20.5 Lake Management Recent Developments
11.21 Acti-Zyme
11.21.1 Acti-Zyme Company Details
11.21.2 Acti-Zyme Business Overview
11.21.3 Acti-Zyme Biological Augmentation Services Introduction
11.21.4 Acti-Zyme Revenue in Biological Augmentation Services Business (2018-2023)
11.21.5 Acti-Zyme Recent Developments
11.22 Aquatic Plus Pond Management
11.22.1 Aquatic Plus Pond Management Company Details
11.22.2 Aquatic Plus Pond Management Business Overview
11.22.3 Aquatic Plus Pond Management Biological Augmentation Services Introduction
11.22.4 Aquatic Plus Pond Management Revenue in Biological Augmentation Services Business (2018-2023)
11.22.5 Aquatic Plus Pond Management Recent Developments
11.23 Oxybeesolutions
11.23.1 Oxybeesolutions Company Details
11.23.2 Oxybeesolutions Business Overview
11.23.3 Oxybeesolutions Biological Augmentation Services Introduction
11.23.4 Oxybeesolutions Revenue in Biological Augmentation Services Business (2018-2023)
11.23.5 Oxybeesolutions Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Black Lagoon
SOLitude Lake Management
Estate Management Services
LakePro
OMEX
RF WasteWater
SUEZ
Aquatic Biologists
Parklink
WET USA
Barber's Chemicals
Madep
Amanzi Matters
Cholamandalam MS Risk Services
Cellozyme
Skyhawk Global
Hagan Engineering
Kurita Water Industries
MER Chemical Laboratory and Services
Lake Management
Acti-Zyme
Aquatic Plus Pond Management
Oxybeesolutions
Ìý
Ìý
*If Applicable.
